Search

The article focuses on the pharmaceutical company Novartis and the patent expiration of its heart medication Diovan in September of 2012. Topics include Indian pharmaceutical company Ranbaxy Laboratories' exclusive right to create Diovan in India and U.S. regulators decision to prevent the distribution of Diovan in India due to concerns over unsafe working conditions in Ranbaxy factories.

The article discusses the efforts of the GlaxoSmithKline pharmaceutical company to promote consumer products with a focus on marketing of the Horlicks milk drink in India. Topics include the increase in non-pharmaceutical sales for the company, the business strategy of the company to invest in emerging markets, and the amount of funds spent on research in consumer products.